Please login to the form below

Not currently logged in
Email:
Password:

Multidrug resistant infection

This page shows the latest Multidrug resistant infection news and features for those working in and with pharma, biotech and healthcare.

FDA green lights study of phage-based drug for resistant infections

FDA green lights study of phage-based drug for resistant infections

Possible alternative to conventional antibiotics. With multidrug resistant (MDR) infections on the rise worldwide, researchers have started looking at using bacteriophages – viruses that only infect bacteria – as an alternative to a ... alongside

Latest news

  • Tackling the TB threat

    However, the continued health, social and economic problems that the disease poses, alongside the emergence of multidrug-resistant forms and rising infection rates in the developed world, have renewed interest in ... A complication is the emergence of

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
The Good Ideas Group

Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....